The Food and Drug Administration on April 7 approved Sovaldi and Harvoni to treat the hepatitis C virus in patients ages 12 to 17. The drugs, developed by Gilead Sciences, represent the first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results